These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15379734)

  • 21. Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.
    Čipčić Paljetak H; Verbanac D; Padovan J; Dominis-Kramarić M; Kelnerić Ž; Perić M; Banjanac M; Ergović G; Simon N; Broskey J; Holmes DJ; Eraković Haber V
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5337-48. PubMed ID: 27353268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformations in solution and bound to bacterial ribosomes of ketolides, HMR 3647 (telithromycin) and RU 72366: a new class of highly potent antibacterials.
    Evrard-Todeschi N; Gharbi-Benarous J; Gaillet C; Verdier L; Bertho G; Lang C; Parent A; Girault JP
    Bioorg Med Chem; 2000 Jul; 8(7):1579-97. PubMed ID: 10976506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
    Poehlsgaard J; Douthwaite S
    Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrolide resistance from the ribosome perspective.
    Franceschi F; Kanyo Z; Sherer EC; Sutcliffe J
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):177-91. PubMed ID: 15379729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
    Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
    BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of Erm-modified 70S ribosome reveals the mechanism of macrolide resistance.
    Svetlov MS; Syroegin EA; Aleksandrova EV; Atkinson GC; Gregory ST; Mankin AS; Polikanov YS
    Nat Chem Biol; 2021 Apr; 17(4):412-420. PubMed ID: 33462493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
    Fernandes P; Pereira D; Watkins PB; Bertrand D
    J Med Chem; 2020 Jun; 63(12):6462-6473. PubMed ID: 31644280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.
    Zhanel GG; Hisanaga T; Nichol K; Wierzbowski A; Hoban DJ
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):297-321. PubMed ID: 14661991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational analysis of ketolide, conformations of RU 004 in solution and bound to bacterial ribosomes.
    Bertho G; Gharbi-Benarous J; Delaforge M; Lang C; Parent A; Girault JP
    J Med Chem; 1998 Aug; 41(18):3373-86. PubMed ID: 9719590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced Methods for Studying Structure and Interactions of Macrolide Antibiotics.
    Jednačak T; Mikulandra I; Novak P
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments on ketolides and macrolides.
    Wu YJ; Su WG
    Curr Med Chem; 2001 Dec; 8(14):1727-58. PubMed ID: 11562291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.
    Arthur M; Brisson-Noël A; Courvalin P
    J Antimicrob Chemother; 1987 Dec; 20(6):783-802. PubMed ID: 3326871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of drug-ribosome interactions defines the cidality of macrolide antibiotics.
    Svetlov MS; Vázquez-Laslop N; Mankin AS
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13673-13678. PubMed ID: 29229833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythromycin, Cethromycin and Solithromycin display similar binding affinities to the E. coli's ribosome: A molecular simulation study.
    Nguyen HL; An PH; Thai NQ; Linh HQ; Li MS
    J Mol Graph Model; 2019 Sep; 91():80-90. PubMed ID: 31200217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of bacterial resistance to macrolide antibiotics.
    Nakajima Y
    J Infect Chemother; 1999 Jun; 5(2):61-74. PubMed ID: 11810493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural consideration of macrolide antibiotics in relation to the ribosomal interaction and drug design.
    Takashima H
    Curr Top Med Chem; 2003; 3(9):991-9. PubMed ID: 12678833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.
    Poce G; Cesare Porretta G; Biava M
    Expert Opin Ther Pat; 2009 Jun; 19(6):901-6. PubMed ID: 19473109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketolides: the future of the macrolides?
    Nilius AM; Ma Z
    Curr Opin Pharmacol; 2002 Oct; 2(5):493-500. PubMed ID: 12324249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrolide resistance based on the Erm-mediated rRNA methylation.
    Maravić G
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):193-202. PubMed ID: 15379730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.